To verify our hypothesis, we assessed the expression of YAP/TAZ in NRP2-sh CAF-CM-treated cancer cells and found that YAP/TAZ significantly diminished, compared with NRP2-nc CAF-CM-treated cancer cells. Here, NRP2 is linked to cancer.